Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study.

Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators.

Lancet Infect Dis. 2011 Mar;11(3):181-9. doi: 10.1016/S1473-3099(10)70314-5. Epub 2011 Jan 20.

PMID:
21256086
2.

Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.

Becher RD, Hoth JJ, Rebo JJ, Kendall JL, Miller PR.

Surg Infect (Larchmt). 2012 Dec;13(6):352-9. doi: 10.1089/sur.2011.056.

PMID:
23268613
3.

Effects of adherence to ventilator-associated pneumonia treatment guidelines on clinical outcomes.

Sakaguchi M, Shime N, Iguchi N, Kobayashi A, Takada K, Morrow LE.

J Infect Chemother. 2013 Aug;19(4):599-606. doi: 10.1007/s10156-012-0522-4. Epub 2012 Nov 28.

PMID:
23188167
4.

Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study.

Mangino JE, Peyrani P, Ford KD, Kett DH, Zervos MJ, Welch VL, Scerpella EG, Ramirez JA; IMPACT-HAP Study Group.

Crit Care. 2011;15(1):R38. doi: 10.1186/cc9988. Epub 2011 Jan 25.

5.

[Actualities of adults' ventilator-associated pneumonia].

Svediene S, Ivaskevicius J.

Medicina (Kaunas). 2006;42(2):91-7. Review. Lithuanian.

6.
7.

Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit.

Ferrer M, Liapikou A, Valencia M, Esperatti M, Theessen A, Antonio Martinez J, Mensa J, Torres A.

Clin Infect Dis. 2010 Apr 1;50(7):945-52. doi: 10.1086/651075.

PMID:
20175690
8.

Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.

Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M, Wolkewitz M.

Lancet Infect Dis. 2011 Jan;11(1):30-8. doi: 10.1016/S1473-3099(10)70258-9. Epub 2010 Dec 2.

PMID:
21126917
9.

Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.

Torres A, Ferrer M, Badia JR.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S48-53. doi: 10.1086/653049. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

PMID:
20597672
10.

Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.

Rello J, Ulldemolins M, Lisboa T, Koulenti D, MaƱez R, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E; EU-VAP/CAP Study Group.

Eur Respir J. 2011 Jun;37(6):1332-9. doi: 10.1183/09031936.00093010. Epub 2010 Sep 16.

11.

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group.

Clin Ther. 2012 Jan;34(1):149-57. doi: 10.1016/j.clinthera.2011.12.013.

PMID:
22284995
12.

Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.

Weiss E, Dahmani S, Bert F, Janny S, Sommacale D, Dondero F, Francoz C, Belghiti J, Mantz J, Paugam-Burtz C.

Liver Transpl. 2010 Oct;16(10):1178-85. doi: 10.1002/lt.22132.

13.

Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.

Arnold HM, Sawyer AM, Kollef MH.

Respir Care. 2012 Aug;57(8):1226-33. doi: 10.4187/respcare.01556. Epub 2012 Feb 17.

15.

[Guidelines for treatment of pneumonia in intensive care units].

Emmi V.

Infez Med. 2005;Suppl:7-17. Review. Italian.

16.

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes.

Piskin N, Aydemir H, Oztoprak N, Akduman D, Comert F, Kokturk F, Celebi G.

BMC Infect Dis. 2012 Oct 24;12:268. doi: 10.1186/1471-2334-12-268.

17.

Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines.

Kuti JL, Shore E, Palter M, Nicolau DP.

Semin Respir Crit Care Med. 2009 Feb;30(1):102-15. doi: 10.1055/s-0028-1119814. Epub 2009 Feb 6. Review.

PMID:
19199192
18.
19.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
20.

Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.

Nseir S, Grailles G, Soury-Lavergne A, Minacori F, Alves I, Durocher A.

Clin Microbiol Infect. 2010 Jul;16(7):902-8. doi: 10.1111/j.1469-0691.2009.03027.x. Epub 2009 Aug 20.

Supplemental Content

Support Center